FI881878A - 17 -(cyklopropyloxi) androst-5-en -3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20 lyas inhibitorer. - Google Patents

17 -(cyklopropyloxi) androst-5-en -3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20 lyas inhibitorer. Download PDF

Info

Publication number
FI881878A
FI881878A FI881878A FI881878A FI881878A FI 881878 A FI881878 A FI 881878A FI 881878 A FI881878 A FI 881878A FI 881878 A FI881878 A FI 881878A FI 881878 A FI881878 A FI 881878A
Authority
FI
Finland
Prior art keywords
som
androst
naerstaoende
cyclopropyloxi
inhibitorer
Prior art date
Application number
FI881878A
Other languages
English (en)
Other versions
FI881878A0 (fi
FI87791C (fi
FI87791B (fi
Inventor
Michael R Angelastro
Thomas R Blohm
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI881878A0 publication Critical patent/FI881878A0/fi
Publication of FI881878A publication Critical patent/FI881878A/fi
Application granted granted Critical
Publication of FI87791B publication Critical patent/FI87791B/fi
Publication of FI87791C publication Critical patent/FI87791C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
FI881878A 1987-04-22 1988-04-21 Foerfarande foer framstaellning av 17 -(cyklopropyloxi)androst-5-en-3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20 lyas inhibitorer FI87791C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/041,170 US4891367A (en) 1987-04-22 1987-04-22 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4117087 1987-04-22

Publications (4)

Publication Number Publication Date
FI881878A0 FI881878A0 (fi) 1988-04-21
FI881878A true FI881878A (fi) 1988-10-23
FI87791B FI87791B (fi) 1992-11-13
FI87791C FI87791C (fi) 1993-02-25

Family

ID=21915121

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881878A FI87791C (fi) 1987-04-22 1988-04-21 Foerfarande foer framstaellning av 17 -(cyklopropyloxi)androst-5-en-3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20 lyas inhibitorer

Country Status (20)

Country Link
US (1) US4891367A (fi)
EP (1) EP0291717B1 (fi)
JP (1) JP2593685B2 (fi)
KR (1) KR960015036B1 (fi)
CN (1) CN1024279C (fi)
AT (1) ATE78487T1 (fi)
AU (1) AU605575B2 (fi)
CA (1) CA1309088C (fi)
DE (1) DE3872938T2 (fi)
DK (1) DK167766B1 (fi)
ES (1) ES2051787T3 (fi)
FI (1) FI87791C (fi)
GR (1) GR3005370T3 (fi)
HU (1) HU198508B (fi)
IL (1) IL86140A (fi)
NO (1) NO168892C (fi)
NZ (1) NZ224287A (fi)
PH (1) PH23863A (fi)
PT (1) PT87293B (fi)
ZA (1) ZA882715B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606677B2 (en) * 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5051534A (en) * 1990-03-22 1991-09-24 Merrell Dow Pharmaceuticals Inc. Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
US5102915A (en) * 1990-03-22 1992-04-07 Merrell Dow Pharmaceuticals Inc. Cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
WO2003039250A2 (en) * 2001-11-08 2003-05-15 Colorado State University Research Foundation Termite feeding stimulant and method for using same
WO2008157460A1 (en) * 2007-06-15 2008-12-24 Cook, Kevin, M. Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135744A (en) * 1961-04-12 1964-06-02 Vismara Francesco Spa Cycloalkenyl ethers of 17 beta-hydroxy androstanes
CH471103A (de) * 1962-02-28 1969-04-15 Warner Lambert Pharmaceutical Verfahren zur Herstellung neuer (1'-Alkoxy)-alkyl- und cycloalkyläther von 17B-Hydroxysteroiden
US3475464A (en) * 1966-11-07 1969-10-28 Syntex Corp Process for the preparation of steroids and novel intermediates thereof
US3732209A (en) * 1971-03-15 1973-05-08 Hoffmann La Roche Novel 17beta-oxygenated cyclopropa(16alpha,17alpha)steroids
US3763146A (en) * 1972-02-03 1973-10-02 Syntex Corp Novel 17beta(tetrahydropyran-4-yloxy)steroids
US4139617A (en) * 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4420428A (en) * 1982-12-27 1983-12-13 E. R. Squibb & Sons, Inc. 16-Ketoandrostene-17-dithioketals
US4427592A (en) * 1983-01-31 1984-01-24 E. R. Squibb & Sons, Inc. Androstene-17-dithioketals
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
AU606677B2 (en) * 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
DK217488D0 (da) 1988-04-21
CN1024279C (zh) 1994-04-20
ES2051787T3 (es) 1994-07-01
PT87293B (pt) 1992-08-31
FI881878A0 (fi) 1988-04-21
DE3872938T2 (de) 1993-01-07
NO881745D0 (no) 1988-04-21
ATE78487T1 (de) 1992-08-15
KR960015036B1 (ko) 1996-10-24
AU605575B2 (en) 1991-01-17
HU198508B (en) 1989-10-30
NO881745L (no) 1988-10-24
KR880012634A (ko) 1988-11-28
PT87293A (pt) 1988-05-01
NO168892B (no) 1992-01-06
ZA882715B (en) 1988-10-17
AU1472088A (en) 1988-10-27
US4891367A (en) 1990-01-02
CN88102175A (zh) 1988-11-16
FI87791C (fi) 1993-02-25
FI87791B (fi) 1992-11-13
CA1309088C (en) 1992-10-20
IL86140A0 (en) 1988-11-15
NZ224287A (en) 1989-11-28
JPS63284194A (ja) 1988-11-21
EP0291717A1 (en) 1988-11-23
PH23863A (en) 1989-11-23
HUT47305A (en) 1989-02-28
GR3005370T3 (fi) 1993-05-24
JP2593685B2 (ja) 1997-03-26
DE3872938D1 (de) 1992-08-27
DK217488A (da) 1988-10-23
EP0291717B1 (en) 1992-07-22
DK167766B1 (da) 1993-12-13
IL86140A (en) 1993-02-21
NO168892C (no) 1992-04-15

Similar Documents

Publication Publication Date Title
ES2090064T3 (es) 17beta-(ciclopropiloxi)androst-5-en-3beta-ol 4-sustituido y compuestos relacionados que son inhibidores de liasa c17-20.
FI881877A0 (fi) 17 -(cyklopropylamino) androst-5 -en-3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20-lyas-inhibitorer.
FI881878A0 (fi) 17 -(cyklopropyloxi) androst-5-en -3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20 lyas inhibitorer.
MX9200793A (es) Tetrahidropirinas y metodo para su preparacion.
IS1657B (is) Aðferð til að framleiða olíukennda blöndu
EP0137289A3 (en) Process for the preparation of silica polymorphs from silicon
DK431287D0 (da) Fremgangsmaade til fremstilling af 1,3-glycoler
FR2569068B1 (fr) Appareil de decodage de codes d'image obtenus par un processus de compression
IL65597A (en) Preparation of 1alpha,24,25-trihydroxy-and 24,25-dihydroxy-cholesterol and certain novel intermediates used therein
DE3162611D1 (de) Method of gas-chromizing steels
FI891475A (fi) Foerfarande foer framstaellning av natriumfluoralkoholat.
FR2616937B1 (fr) Transcodeur de controle du processus de lecture-comparaison d'un document code
HUT47616A (en) Curable rubber mixture comprising substituted n-trichloro-methyl-thiohydantoins and bis(2,4-diamino-s-triazin-6-yl)-oligosulfides and process for producing same
FR2612172B1 (fr) Procede de preparation de polychlorophosphazene
IT1227166B (it) Processo per la preperazione di 4metiltiobenzaldeide.
RO70234A2 (ro) Procedeu de obtinere a silicei coloidale

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.